Study on the different expression of molecular markers between cardiac cancer and distal gastric cancer and their correlations with clinicopathological features

Digestive Surgery

Volumn 26, Issue 5, 2009, Pages 384-391

  Ye, Yan Wei ^a   Fu, Hong ^a   Zhou, Ye ^a   Du, Chun Yan ^a   Li, Bai Zhou ^a   Zhu, Lei ^a   Shi, Ying Qiang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Cardiac cancer; Distal gastric cancer; Immunohistochemistry; Pathology

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; CARDIA; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA-BINDING PROTEINS; FEMALE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; MALE; MIDDLE AGED; NEURAMINIDASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 70449635986     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000226766     Document Type: Article

References (29)

1. Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-2150.
2. Blot WJ, Devesa SS, Kneller RW, et al: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-1289.
3. Suerbaum S, Michetti P: Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186.
4. Akiyama T, Sudo C, Ogawara H, et al: The product of the human c-erbB-2 gene: a 185- kilodalton glycoprotein with tyrosine kinase activity. Science 1986; 232: 1644-1646.
5. Coussens L, Yang-Feng TL, Liao YC, et al: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with Neu oncogene. Science 1985; 230: 1132-1139.
6. Fenoglio-Preiser CM, Wang J, Stemmermann GN, et al: TP53 and gastric carcinoma: a review. Hum Mutat 2003; 21: 258-270.
7. Wiksten JP, Lundin J, Nordling S, et al: The prognostic value of p27 in gastric cancer. Oncology 2002; 63: 180-184.
8. Feakins RM, Mulcahy HE, Quaglia A, et al: p27(Kip1) loss does not predict survival in patients with advanced gastric carcinoma. Cancer 2000; 89: 1684-1691.
9. Nitti D, Belluco C, Mammano E, et al: Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome. J Surg Oncol 2002; 81: 167-175.
10. Liu XP, Kawauchi S, Oga A, et al: Combined examination of p27(Kip1), p21(Waf1/Cip1), and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma. Histopathology 2001; 39: 603-610.
11. Zhang H, Fang DC, Wang RQ, et al: Effect of Helicobacter pylori infection on expression of Bcl-2 family members in gastric adenocarcinoma. World J Gastroenterol 2004; 10: 227-230.
12. Sherr CJ: Cancer cell cycles. Science 1996; 274: 1672-1677.
13. Massague J, Blain SW, Lo RS: TGF- β signaling in growth control, cancer, and heritable disorders. Cell 2000; 103: 295-309.
14. Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501-1512.
15. Hamilton SR, Aaltonen LA: Pathology and Genetics of Tumors of the Digestive System. World Health Organization Classification of Tumors. Lyon, IARCP, 2000.
16. Greene FL, Page DL, Fleming ID, et al: AJCC Cancer Staging Manual, ed 6. New York, Springer, 2002.
17. Kwon HC, Roh MS, Oh SY, et al: Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/ oxaliplatin chemotherapy in advanced gastric cancer. Ann Oncol 2007; 18: 504-509.
18. Al-Moundhri MS, Nirmala V, Al-Hadabi I, et al: The prognostic significance of p53, p27 Kip1, p21 Waf1, HER-2/Neu, and Ki-67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. J Surg Oncol 2005; 91: 243-252.
19. Pacelli F, Papa V, Caprino P, et al: Proximal compared with distal gastric cancer: multivariate analysis of prognostic factors. Am Surg 2001; 67: 697-703.
20. Pinto-de-Sousa J, David L, Almeida R, et al: c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma. Int J Surg Pathol 2002; 10: 247-256.
21. Mattioli E, Vogiatzi P, Sun A, et al: Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(Kip1), p21- (Waf1), Ki-67 expression patterns in gastric cancer. J Cell Physiol 2007; 210: 183-191.
22. Heng JD, Werness BA, Babb JS, et al: Paradoxical correlations of cyclin-dependent kinase inhibitors p21Waf1/cip1 and p27Kip1 in metastatic colorectal carcinoma. Clin Cancer Res 1999; 5: 1057-1062.
23. Polyak K, Kato J, Solomon M, et al: p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor- β and contact inhibition to cell cycle arrest. Genes Dev 1994; 8: 9-22.
24. Oijen AH, Verhulst ML, Roelofs HM, et al: Eradication of Helicobacter pylori restores glutathione S-transferase activity and glutathione levels in antral mucosa. Jpn J Cancer Res 2001; 92: 1329-1334.
25. Wang X, Wang L, Yuan Y: Expression of pi glutathione S-transferase in intestinal metaplasia and its relationship with Helicobacter pylori infection. Zhonghua Yi Xue Za Zhi 2002; 82: 1033-1036.
26. Ashktorab H, Daremipouran M, Wilson M, et al: Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer. Am J Gastroenterol 2007; 102: 2135-2146.
27. Udhayakumar G, Jayanthi V, Devaraj N, et al: Interaction of MUC1 with β -catenin modulates the Wnt target gene cyclin D1 in H. pylori -induced gastric cancer. Mol Carcinog 2007; 46: 807-817.
28. Petersson F, Borch K, Franzen LE: Gastric epithelial proliferation and p53 and p21 expression in a general population sample: relations to age, sex, and mucosal changes associated with H. pylori Infection. Dig Dis Sci 2002; 47: 1558-1566.
29. Eguchi H, Herschenhous N, Kuzushita N, et al: Helicobacter pylori increases proteasomemediated degradation of p27(Kip1) in gastric epithelial cells. Cancer Res 2003; 63: 4739-4746.